Overview
Andrew Fry practices practicing medicine in Kidlington, United Kingdom.
His clinical expertise encompasses Lung Cancer, Mesothelioma, Non-Small Cell Lung Cancer (NSCLC), and Acute Tubular Necrosis.
He is actively involved in clinical research, co-authoring 73 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Andrew M. Fry
Is Andrew M. Fry a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Andrew M. Fry is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Andrew M. Fry participate in research or clinical trials?
Yes. Andrew M. Fry has published 73 articles and abstracts on conditions like Lung Cancer. You can view a list of Andrew M. Fry's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Tubular NecrosisMr. Fry isExperienced. Learn about Acute Tubular Necrosis.
- Lung CancerMr. Fry isExperienced. Learn about Lung Cancer.
- MesotheliomaMr. Fry isExperienced. Learn about Mesothelioma.
- Non-Small Cell Lung Cancer (NSCLC)